Andere talen GuiZhou SanLi Pharmaceutical Co.,Ltd

Aandelen

603439

CNE1000040B4

slotkoers Shanghai S.E. Andere beurzen 00:00:00 20-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
15,77 ^CNY	-0,13%		-3,25%	-16,47%

26/04	Guizhou Sanli Pharmaceutical Co.,Ltd rapporteert resultaten voor het eerste kwartaal eindigend op 31 maart 2024	CI
26/04	Guizhou Sanli Pharmaceutical Co.,Ltd rapporteert resultaten voor het volledige jaar eindigend op 31 december 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Guizhou Sanli Pharmaceutical Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	26/04
Guizhou Sanli Pharmaceutical Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	26/04
Tranche Update on Guizhou Sanli Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on November 4, 2023.	09/12
Guizhou Sanli Pharmaceutical Co.,Ltd's Equity Buyback announced on November 4, 2023, has closed with 1,550,900 shares, representing 0.38% for CNY 29.99 million.	07/12
Guizhou Sanli Pharmaceutical Co.,Ltd announces an Equity Buyback for CNY 40 million worth of its shares.	04/11
Guizhou Sanli Pharmaceutical Co.,Ltd authorizes a Buyback Plan.	03/11
Guizhou Sanli Pharmaceutical Co.,Ltd completed the acquisition of 50.26% stake in Guizhou Hanfang Pharmaceutical Co., Ltd. from Gui'an New District Shunqi Commercial Operation Management Center (Limited Partnership) and Sheng Yongjian.	30-10-23
Shanghai Guosheng Haitong Private Enterprise High-Quality Development Private Investment Fund and Shanghai Guosheng Capital Management Co., Ltd. completed the acquisition of 5.0017% stake in Guizhou Sanli Pharmaceutical Co.,Ltd(SHSE:603439) from Wang Huiying.	30-10-23
Guizhou Sanli Pharmaceutical Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	27-10-23
Guizhou Sanli Pharmaceutical Co.,Ltd agreed to acquire a stake in Guizhou Hanfang Pharmaceutical Co., Ltd. from Gui'an New District Shunqi Commercial Operation Management Center (Limited Partnership) and Sheng Yongjian	23-09-23
Guizhou Sanli Pharma Plans Acquisition for CNY 499.6 Million	22-09-23
Guizhou Sanli Pharmaceutical Co.,Ltd(XSSC:603439) added to S&P Global BMI Index	18-09-23
Guizhou Sanli Pharmaceutical Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	30-08-23
Shanghai Guosheng Haitong Private Enterprise High-Quality Development Private Investment Fund and Shanghai Guosheng Capital Management Co., Ltd. entered into 5.0017% stake in Guizhou Sanli Pharmaceutical Co.,Ltd from Wang Huiying for CNY 322.875 million.	31-07-23
GuiZhou SanLi Pharmaceutical Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	28-04-23
Certain A Shares of GuiZhou SanLi Pharmaceutical Co.,LTD. are subject to a Lock-Up Agreement Ending on 28-APR-2023.	28-04-23
GuiZhou SanLi Pharmaceutical Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2022	14-04-23
Guizhou Sanli Pharma Sees Up to 42.5% Jump in 2022 Profit	09-01-23
Guizhou Sanli Pharma Elects Vice Chairman	29-12-22
GuiZhou SanLi Pharmaceutical Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022	28-10-22

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen GuiZhou SanLi Pharmaceutical Co.,Ltd

Aandelen

603439

CNE1000040B4

Andere talen

Filters